Search Results
Results found for "Can Cao"
- Dr. GPCR and GeneTex Partner to Engage the Community on Anti-GPCR Antibody Challenges
When antibodies fail to selectively recognize GPCR targets, the resulting data can be difficult to reproduce When antibody specificity is uncertain, variability in experimental outcomes can propagate across studies
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
In the meantime, you can get a sneak peek by exploring Terry's Articles , which offer complementary insights
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
When the endogenous binder of the GPCR (which can be a neuromodulator, neurotransmitter, etc.), binds Depending on the type of GPCR, it can lead to different secondary messengers , like cAMP, IP3, which advantages of using fluorescent ligands for this are: Live-cell imaging: Â receptor-ligand interactions can
- VAMP2: a crucial player in the delivery of MOR to the synapse
In addition, VAMP2 can interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid in the case of MOR, which is a receptor with several splicing variants, its traffic to the membrane can the integrity of its bi-leucine sequence (which is considered a key element in its recycling), which can receptor regulates pain perception and reward, the dysfunction in the MOR-SNARE complex interaction can You can consult the article at the following link: https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Weâre zeroing in on kinetic tools that reveal what steady-state data canâtâso you can vet leads faster These are the pattern-recognition tools that convert uncertainty into decisions you can defend at a project Weâve got your GPCR Track, Happy Hour, and sessions mapped so you can extract maximum value.
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
two reasons why researchers typically require years to uncover the mechanisms of disease before they can potential toxicities and side effects, and these key factors must be deemed tolerable before investigators can cells, has the drawback of causing damage to healthy cells in the process, leading to side effects that can
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
. đ See how Celtarys can support your drug discovery workflow on the company page . _______________
- How to Avoid the Most Common Gaps in Your Biotech Pitch
The Most Common Mistakes in Biotech Pitches Even the most brilliant science can get lost in a poor pitch And the good news is, they can be fixed. Strong biotech pitches donât just inform, they align. When the listener knows exactly who your solution targets, they can immediately place it in their mental
- Antibodies That Donât Block, They Activate: A New Angle on Autoimmunity and GPCRs
The Tools to Detect Them Using the multiplexed GPCR library and Luminex assay , researchers can now:
- Why Fundraising Mistakes Kill Strong Biotech Startups
impact on biotech companies, how these patterns emerge in otherwise well-run teams, and what founders can Teams begin to prioritize what can be explained easily over what actually matters most. understand less clearly why certain priorities exist, creating silent friction. đ Each of these decisions can This is why strong biotech startups can lose their strategic center without any dramatic turning point
- đ° GPCR Weekly News, April 29 to May 5, 2024
In the meantime, you can always check the  Classified GPCR News from the last weeks.
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
actually optimizing for, and where most early-stage teams fall short: 1ď¸âŁ Predictable safety margins: Can 3ď¸âŁ Manufacturing consistency: Can you show that your process will be scalable, repeatable, and GMP-compliant doubt slows down approval. â The sooner you understand what theyâre optimizing for, the faster you can
- Chemerin Forms: Their Generation and Activity
Chemerin can signal via two G protein-coupled receptors, chem1 and chem2, as well as be bound to a third and secreted into the circulation as a precursor, but it is also expressed in some tissues where it can
- Reflections on My PhD Journey: Lessons Learned
generating data when experiments are working smoothly, but neglecting to analyze that data in real-time can One of the best pieces of advice I can give is to analyze your results as you progress.
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors (GPCRs) and can Further, we show that 14 can be used as a tool for fragment-based screening approaches.
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Showing that this spatially biased signaling through arrestins can influence transcriptional responses addition to endosomal signaling, GPCRs are also known to localize to the Golgi apparatus, where they can Activation of nuclear GPCRs, such as the metabotropic glutamate receptor 5 (mGluR5), can lead to sustained both temporal and spatial components, sustained signaling responses from intracellular compartments can Additionally, the conditions within endosomes, such as low pH and high protease activity, can degrade
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
AR can become AR* or ARG, raising apparent affinity. When G proteins are abundant, curves look clean because every receptorâligand complex can couple. producing reliable orthosteric binding measurements: Cell type and receptor expression: Â Overexpression can
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
Mapping of Alphafold2 generated models of these proteins confirms that the same sites can be identified These sites cluster at nine distinct locations, and each can be found in many different proteins.
- đ° GPCR Weekly News, February 27 to March 5, 2023
Keep in mind that you can always change your email preferences in your account settings. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that we can add it to the list of posters and increase the number of people who can ''stop by'' it on March
- đ° GPCR Weekly News, March 13 to 19, 2023
Remember, you can always adjust your email preferences in your account settings. For Dr. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that we can add it to the list of posters and increase the number of people who can ''stop by'' it tomorrow
- How System-Level GPCR Thinking Prevents Discovery Failures
What Youâll Gain Spot false confidence early  â Sensitivity differences can turn full agonists into partials His work shows why chemical design can outperform antibodies and how rigorous assay validation bridges
- Nuclear localization of histamine receptor 2 in primary human lymphatic endothelial cells
imparts many unresolved questions, such as the functional relevance of this localization, and whether H2R can contribute directly to transcriptional regulation and can affect lymphatic specific gene expression.
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
Kenakin, these five modules reveal how location bias, intracellular signaling, and ligand kinetics can
- From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science
âYou can guide them to learn the technique and go over it.
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Receptor localization, ligand access, and intracellular signaling can look different in actual tissues Can GPCRs act as âdelivery ZIP codesâ for targeted therapies?
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function
- How GPCR Collaboration Built an Innovation Engine
partnerships take root Today  â Model continues to produce high-impact GPCR science What the Rest of the Field Can GPCR science thrives in complexity â meaning no single lab or company can do it alone.
- Transmembrane domains of GPCR dimers â a novel hot spot for drug discovery
Transmembrane domains of GPCR dimers â a novel hot spot for drug discovery G-protein-coupled receptors (GPCRs) can form biologically active homodimers or heterodimers which drive specific signaling pathways that can But how can we target GPCR dimers? Recent studies found that peptides derived from the transmembrane region of GPCRs can block the formation
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation "The process of GPCR dimerization can SST2 and SST5 can also form endogenous hetero-dimers in these cells. In conclusion, we demonstrated that in GH3 cells SST2 and SST5 can form both homo- and hetero-dimers
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
excitatory neurotransmitter of the nervous central system, L-glutamate, and mGlu5 receptor activity can illustrate how access to high-resolution structures of GPCRs in complex with allosteric modulators can
















